Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

C4 Therapeutics (CCCC) Accumulated Depreciation & Amortization (2019 - 2025)

C4 Therapeutics (CCCC) has 7 years of Accumulated Depreciation & Amortization data on record, last reported at $1.5 million in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 14.42% year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, up 14.42%, while the annual FY2024 figure was $9.2 million, 18.97% up from the prior year.
  • Accumulated Depreciation & Amortization reached $1.5 million in Q3 2025 per CCCC's latest filing, up from $1.1 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $9.2 million in Q4 2024 and bottomed at $448000.0 in Q1 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $4.3 million, with a median of $3.8 million recorded in 2021.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 22.8% in 2021, then tumbled 86.5% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $6.9 million in 2021, then rose by 17.45% to $8.1 million in 2022, then dropped by 4.43% to $7.8 million in 2023, then grew by 18.97% to $9.2 million in 2024, then plummeted by 83.42% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $1.5 million in Q3 2025, $1.1 million in Q2 2025, and $456000.0 in Q1 2025.